MCL1 inhibitor PRT1419 Demonstrates Antitumor Activity in PBRM1-altered Clear Cell Renal Cancer and Synergizes with Standard of Care Agents

Norman Fultang, Ashley M. Schwab, Brian Vidal Torres, Alexander Grego, Stephanie Rodgers, Diane Heiser, Kris Vaddi, Neha Bhagwat, Peggy Scherle